When a subject's change of residence was detected in registration records, we requested registration records in the cities or towns where they were currently living. The details, including date of death, of subjects who had died were taken from registration records. The underlying causes of death were derived from the National Vital Statistics. By matching the area code of the place of death, sex, date of birth, and date of death using data from mortality statistics in Japan, the underlying cause of death was determined. Thus, we could identify the cause of death for 99.5% of 1,327 deceased subjects. Using NIPPON DATA80, this follow-up study ascertained the vital status of 9,638 (91.4% of the original 10,546 subjects).
Study Population
Of the 10,546 subjects initially examined in 1980, those excluded from the present study were aged over 90 years and had a history of CVD in the baseline data. After exclusion criteria were applied, 4,347 men and 5,440 women aged between 30 and 89 years without CVD at baseline were identified. Among these subjects, 3,976 (91.5%) of men and 4,962 (91.2%) of women were followed up; these 8,938 subjects were used for the analyses in the current study.
Study Variables and Mortality
The method of risk factor measurement used in the baseline survey of 1980 has been described elsewhere. 13, 15, 16 Briefly, standardized measures were made of blood pressure, height, weight, and serum total cholesterol. Data on drinking and smoking habits and history of diseases were obtained from a self-administered questionnaire. Drinking status was classified as never, formerly, occasionally, or daily. Data on smoking habits were obtained by asking subjects to note whether they were a 'non-', 'current-', or 'ex-' smoker, and, in the case of smokers, recorded the number of cigarettes smoked per day.
Hypertension was defined as a systolic blood pressure (SBP) of 140 mmHg or greater and/or a diastolic blood pressure (DBP) of 90 mmHg or greater, or the regular use of an antihypertensive drug. Hypercholesterolemia was defined as total cholesterol of 220 mg/dl (5.7 mmol/L) or greater. The criteria for diabetes mellitus in these analyses were defined as a casual blood glucose level of 200 mg/dl or greater, or with a current history of diabetes mellitus. Obesity was defined by a body mass index equal to or greater than 25.0 kg/m 2 .
Causes of death were classified according to the International Classification of Diseases, Ninth Revision (ICD-9). CVD deaths were those assigned ICD codes 390 to 459, which include CHD (codes 410-414) and stroke (codes 430-438). Permission to use the National Cardiovascular Survey in 1980 and vital statistics for determining causes of death were obtained from the Management and Coordination Agency, Government of Japan. Statistical Analysis Chi-square tests were used to compare the risk-factor distribution, and the t-test was used to compare the mean of continuous variables between women and men. The ageadjusted death rate was calculated by direct methods with the 1985 model population of Japan as the standard population. Cox proportional hazard models were used to calculate age and multivariate-adjusted hazard ratios and corresponding 95% confidence intervals (CI) of CVD deaths for each risk factor. The assumption that the hazard ratio of the primary exposure remained constant over time for each risk factor was confirmed by Cox regression with time-dependent covariates.
To examine how the sex differences in the risk factors explain the excess CVD risk in men, a model with sex as an independent variable was built with data including both males and females, to which the other risk factors were added to the model as used by Jousilahti et al. 9 The proportion of the excess CVD risk in men that was explained by the sex differences in the risk factors was estimated as follows. The differences in CVD hazard ratios of men vs women before and after adjustment for risk factors was divided by the denominator that subtracted background risk from hazard ratio (men vs women) as [(HR0 -HR1)/(HR0 -1), where HR0 is age-adjusted hazard ratio (men vs women), HR1 is age, and risk factor-adjusted hazard ratio]. 9 We tested for differences in the hazard ratio of CVD between both males and females by including interaction terms between sex and risk factor in the proportional hazard model. The percentage change in modifiable risk with each change or each 10-unit change was calculated by Cox proportional hazard models. Analyses were calculated using the software SPSS 10.0J for Windows (SPSS10.0J for Windows, Standard Version, SPSS, 2000).
The Ethics Committee of Shiga University of Medical Science, Japan, approved the research protocol of the study.
Results

Baseline Characteristics
The distribution of mean and prevalence of risk factors at the baseline of 8,938 subjects is shown in Table 1 . Average age at baseline was 50.0±12.9 (mean ± standard deviation (SD)) years for men and 50.2±13.1 years for women. The means of SBP and DBP, body mass index, and serum cholesterol were lower in men than in women, and higher for serum glucose (p<0.05). Statistically significant differences by sex were found in proportions of current smokers (men, 63.6%; women, 8.7%) and current drinkers (men, 74.9%; women, 19.9%). The prevalence of hypertension and diabetes mellitus was higher in men, and the prevalence of obesity and hypercholesterolemia was higher in women. Average blood pressures of those who took antihypertensive drug were SBP 159±20.1 mmHg (mean ± SD), DBP 92.5±11.9 mmHg in (HR0-1) ; HR0=age-adjusted hazard ratio of men vs women; HR1=age-, and risk factor-adjusted hazard ratio of men vs women. HR0=1.61, 1.77, and 1.56, for CVD, stroke, and coronary heart disease, respectively. ‡ Hypertension was defined as a systolic blood pressure ≥160 mmHg and/or a diastolic blood pressure ≥95 mmHg, or on antihypertensive drug. § Obesity was defined by a body mass index ≥25.0 kg/m 2 . || High cholesterol was defined as total cholesterol ≥220 mg/dl (5.7 mmol/L). ¶ Diabetes mellitus was defined as a casual blood glucose ≥200 mg/dl, or with a present history of diabetes mellitus. **Current drinker was defined as subjects who drink occasionally or daily. HR, hazard ratio; CI, confidence interval; HT, hypertension; DM, diabetes mellitus; CVD, cardiovascular disease. men, and SBP 158.0±21.6 mmHg (mean ± SD), DBP 89.9± 12.8 mmHg in women.
CVD Mortality
The mean (± SD) follow-up periods were 13.0±2.7 years for men and 13.7±2.2 years for women. There were 51,851 person-years of follow-up in the men, and 66,336 personyears in the women. The mean (± SD) of ages at CVD death were 75.5±11.4 years old in men and 78.2±10.4 years old for women. The mean age at CVD death in women was older than that among men (p<0.05). The mean (± SD) of ages at stroke death were 76.4±10.7 years old for men and 77.3±11.2 years old for women, those at CHD death were 71.9±13.3 years old for men and 77.3±10.0 years old for women. The mean age at CHD death in women was older than that in men (p<0.05). Table 2 shows age-adjusted death rates and the hazard ratio of men compared with women for CVD. When adjusted for age, men were 1.60 (95% CI, 1.32-1.94) times more likely to die from CVD than women, and 1.75 (95% CI, 1.33-2.30) times more likely to die from stroke. Table 3 shows risk in men relative to women, and the proportion of excess risk in men which was explained by the sex difference in risk factor for each model. The ageadjusted hazard ratios for men vs women were 1.61 (95% CI, 1.32-1.95) for CVD, 1.77 (95% CI, 1.34-2.33) for stroke, and 1.56 (95% CI, 0.97-2.50) for CHD. The sex difference in smoking explained the largest proportion of risk factor-associated CVD and stroke deaths. As for CVD death, the sex difference in current drinking was negatively associated with excess deaths of men. Overall, 36% of the excess deaths of men from CVD were associated with the gender difference in all risk factors added to the model, and 46% for stroke.
Excess Male CVD Risk Explained by the Differences in Risk Factors
As a result of testing for sex differences in the hazard ratio of risk factors by including interaction terms between sex and risk factor in the proportional hazard model, interactions between risk factors and sex were not statistically significant in the model of developing CVD, stroke, and CHD, with the exception of the interaction between current drinking and sex in the model of developing CVD (data not shown).
Total Mortality and Excess Male Risk Explained by the Differences in Risk Factors
Numbers of total deaths were 606 for men and 506 for women. When adjusted for age, men were 1.70 (95% CI, 1.51-1.92) times more likely to die for total death. The sex difference in smoking explained 25.5% of the excess total deaths of men. Overall, 25% of the excess total deaths of men were associated with the sex difference in all risk factors; hypertension, obesity, high cholesterol, diabetes mellitus, current smoker, and current drinker (data not shown).
Effect of Risk Factors for CVD in Men and Women
The associations between risk factors and deaths from CVD in men and women are shown in Table 4 . In multivariate analysis, hazard ratios of CVD for current smokers were 1.49 in men, and 1.56 in women. Hypertension and diabetes mellitus were also statistically significant risk factors for CVD in both men and women. Hazard ratios of CVD of current male drinkers were 0.63 (with statistical significance), but had no statistical significance for women. For stroke, only high blood pressure was a statistically significant risk factor for both men and women. For coronary heart disease, high cholesterol was a statistically significant risk factor for men, and diabetes mellitus was a statistically significant risk factor for women. Omitted from Table 4 , the observed percentage changes in risk for CVD death with each change in risk factors, a 10 mmHg increase in SBP, 10 mg/dl increase in casual glucose, and smoking, are expected to increase risk by 15.7%, 4.5%, and 50.9% in men, and 8.6%, 5.0%, and 58.9% in women, with statistical significance, respectively. Current drinking is expected to decrease the risk of CVD by 39.1%, a statistical significant value in men, but not in women.
Discussion
In this nationally representative study in Japan, we found that the major determinant of the sex difference in CVD death was the difference in smoking, which explained nearly half of the excess CVD deaths of men. However, the sex difference in the conventional risk factors, including smoking, explained only one-third of the excess CVD deaths of men. The smaller proportion of excess risk explained by all risk factors other than smoking could be attributed to the preventive effect of alcohol intake for CHD. 18 Except for drinking, the hazard ratio for CVD did not differ significantly between men and women.
Our study as well as previous studies 10, 19, 20 found no sex difference in the hazard ratio for CVD of smoking. 10, 19, 20 A previous analysis of 40 cohort studies 20 found no sex difference in the hazard ratio for stroke from smoking, although a meta-analysis found a slightly increased risk in women. 21 A review noted no sex difference in the hazard ratio for CHD from smoking. 8 In contrast, an analysis of 40 cohort studies found that women tend to have a higher hazard ratio for CHD from smoking. 20 These analyses suggest that the hazard ratio of smoking for CVD is not affected or is increased slightly in women. Thus, the excess of CVD deaths in males explained by sex differences in smoking could be attributed mainly to sex differences in the prevalence of smoking.
Sex differences in all of the conventional risk factors explained about one-third of male excess deaths for CVD in our study. A prospective cohort study also showed that differences in conventional risk factors for CVD explained half of the excess CHD deaths in men in Finland, although drinking habits were not included. 9 These data indicate that excess mortality in men can be modified by lifestyle changes.
Study Limitations
One limitation of our study is that we could not follow cardiovascular events during follow-up from the baseline study in 1980, as this study was conducted as a retrospective cohort study in 1994. Another limitation of our study is the potential misclassification of subjects because we examined CVD risk status only at baseline. Using a single measurement to estimate the effect of risk factors can cause regression-dilution bias, 22 and our data might have underestimated the risk factors. Another possible limitation is the potential sex difference when tracking CVD risk factors over time, although a previous 16-year follow-up study found no major sex differences. 23 Other limitations of our study are the inclusion of frequency of drinking to estimate alcohol consumption, the inability to measure a dose effect of smoking, and the inclusion of casual blood glucose concentration, which might have underestimated the prevalence of diabetes or impaired glucose tolerance because these require measurement of fasting glucose concentration or a glucose challenge test. Additionally, we have not investigated the sex differences in the effect of smoking stratified by cigarettes per day for CVD, although men who smoked more than 20 cigarettes per day would have a higher risk for stroke and CHD death than those who smoked 1 to 20 cigarettes per day. 10 That is because our primary purpose was to investigate the effect of sex differences in smoking rates for CVD, and a goal of the intervention relating to smoking would be smoking cessation rather than reducing the numbers of cigarettes per day.
In our sample, the sex difference in smoking represented the largest proportion of risk factor-associated CVD deaths. Sex differences in smoking rates might also explain the large sex differences in CVD deaths in other Asian countries, such as China, Singapore, and the Republic of Korea, where smoking rates vary widely by sex and age-standardized death rates for CVD are higher than in Japan. 13, 24 However, the female smoking rate has been increasing in these countries, and further studies are needed to evaluate whether the recent increase in smoking rates in women reduces the sex differences in CVD mortality using followup data classified according to the ICD-10.
We found sex differences in mortality and risk factors for CVD. Focusing on the risk factors for CVD rather than individual diseases such as stroke or CHD might clarify the total effect of risk factors for CVD, including heart failure and other causes. In particular, heart failure as a cause of death was officially recorded more frequently during the follow-up period in Japan, where the ICD-9 was used until 1994.
Conclusion
In conclusion, our findings from a nationally representative cohort study in Japan indicate that differences in smoking among men and women explain half of the sex differences in CVD deaths. All conventional risk factors for CVD including smoking explained about one-third of the sex difference in CVD deaths. Hence, excess deaths among men from CVD are not inevitable and can be avoided through interventions. In particular, smoking contributes substantially to excess male CVD deaths in areas where the smoking rate is much higher in men than in women.
